Absconding with the Chaperone: Essential Cyclophilin–Gag Interaction in HIV-1 Virions  by Luban, Jeremy
Cell, Vol. 87, 1157–1159, December 27, 1996, Copyright 1996 by Cell Press
Absconding with the Chaperone: Minireview
Essential Cyclophilin–Gag
Interaction in HIV-1 Virions
Jeremy Luban One Cell’s Cyclophilin Is Another Cell’s
Ticket to RuinDepartments of Microbiology and Medicine
Columbia University Does CyP play a role in HIV-1 replication? CyPA, the
member of the CyP family that colocalizes with Gag inCollege of Physicians and Surgeons
701 West 168th Street the cytoplasm, is specifically incorporated into HIV-1
virions via interaction with the Gag polyprotein (BraatenNew York, New York 10032
et al., 1996b; Franke et al., 1994; Thali et al., 1994). Gag
binding to CyPA requires a proline-rich region located
in the center of the CA domain, and mutation of a single
proline, P90, or of the residue immediately precedingRetroviral virion assembly and uncoating are orches-
trated by gag-encoded proteins, including the Capsid it, G89, disrupts CyPA incorporation into virions and
precludes viral replication. Furthermore, cyclosporine Aprotein (CA) which forms the mature virion core. New
genetic and structural data demonstrate that cyclophilin inhibits the production of replication-competent HIV-1
virions by disrupting the Gag–CyPA interaction (BraatenA (CyPA), a cytoplasmic protein best known as the re-
et al., 1996b; Thali et al., 1994).ceptor for the immunosuppressant cyclosporine A,
Though CyPA is incorporated into HIV-1 virions it isforms a stable and essential complex with CA in HIV-1
not required for virion assembly per se: virions renderedvirions. The most recent contribution to this evolving
CyPA-deficient by gag mutation, or by production in thestory, the solution of the three-dimensional structure of
presence of cyclosporine A, are produced at normalthe HIV-1 CA–CyPA complex, is described in a highly
levels and are otherwise indistinguishable from wild-informative paper in this issue of Cell (Gamble et al.,
type virions by standard biochemical criteria (Braaten1996). These data illuminate aspects of the retroviral life
et al., 1996b; Franke et al., 1994; Thali et al., 1994).cycle that had been relatively inaccessible to study and
Nonetheless, disruption of CyPA incorporation causes aevoke questions about the function of the ubiquitous
quantitative reduction in virion infectivity, with the blockcyclophilin family of proteins.
occuring early in the virus life cycle, after membraneThe Many Faces of Gag
fusion, but prior to the initiation of reverse transcriptionThe myristylated Gag polyprotein of HIV-1 and other
(Figure 1). Target cell CyPA is not required for theseretroviruses is sufficient for the formation and release of
early events and cannot rescue CyPA-deficient virions.enveloped virions. Gag recruits other viral components
Two genetic approaches were used to demonstraterequired for infectivity, including genomic RNA and Env
that Gag not only packages CyPA into virions but thatglycoprotein, via direct interactions during assembly.
The protease product of the pol gene cleaves the Gag
polyprotein into several mature proteins: the matrix pro-
tein, which lines the virion envelope; the capsid protein
(CA), which forms the virion core; and the nucleocapsid
zinc-finger protein, which coats the genomic RNA. To
initiate infection of a susceptible cell, extracellular virus
binds to a cell surface receptor, fuses with the plasma
membrane, and delivers the ribonucleoprotein core into
thecytoplasm. In a poorly defined manner, gag-encoded
proteins then dissociate from the complex (uncoating),
or change conformation, allowing reverse transcription
to begin. Finally, gag protein may participate in transport
of the DNA copy of the viral genome to the nucleus, or
in covalent linkage of viral DNA to host chromosomal Figure 1. Model for the Role of Cyclophilin A in HIV-1 Replication
DNA.
The HIV-1 Gag polyprotein (green) is shown forming a virion bud
To identify cellular factors that might be coopted to from the plasma membrane of an infected cell. Viral genomic RNA
help Gag fulfill its many roles, the HIV-1 Gag polyprotein (brown) and envelope glycoprotein (black ball-and-stick figures) are
incorporated into nascent virions via interactions with the Gag poly-was subjected to a yeast two-hybrid screen and found
protein. CyPA (red) from the infected cell cytoplasm is incorporatedto interact with members of the CyP family (Luban et
into virions by the wild-type Gag polyprotein (A), but not by Gagal., 1993). CyPs were originally discovered because of
mutants G89A or P90A, nor by wild-type Gag expressed in the
their affinity for the potent immunosuppressive drug presence of cyclosporine A (B). At the time of virion release from
cyclosporine A (Handschumacher et al., 1984); the CyP– the producer cell, viral protease is activated, and Gag is cleaved to
cyclosporine A complex binds and inactivates the cal- form the CA (blue) and nucleocapsid (yellow) proteins, among other
products. CyPA is associated with the CA protein in the core ofcium-dependent phosphatase calcineurin, thus block-
wild-type virions. Virion membrane fuses with the plasma membraneing signal transduction in activated T-cells (Schreiber
of susceptible target cells, releasing the virion core into the cyto-and Crabtree, 1992). CyP proteins also catalyze the
plasm of the new host cell. CyPA packaged in the wild-type virion
isomerization of peptidyl-prolyl bonds between the cis then destabilizes the core, permitting the initiation of reverse tran-
and trans states, though the biological significance of scription. CyPA-deficient virion cores cannot be rescued by CyPA
present within the new host-cell cytoplasm.this activity has never been clearly demonstrated.
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a gag-encoded function requires CyPA. Cyclosporine
A-resistant HIV-1 isolates were selected in tissue culture
by passage of virus in the presence of the drug, and the
drug-resistant phenotype was shown to be conferred
by either of two gag missense mutations, A92E or G94D
(Aberham et al., 1996). Although the amino acids altered
by the drug resistance mutations are located in the im-
mediate vicinity of residues G89 and P90, they have no
effect on Gag’s CyPA-binding properties (Braaten et al.,
1996a), indicating that CyPA-binding and CsA-resis-
tance are genetically separable properties in gag. CsA-
resistance results because the mutations confer CyPA-
independence upon HIV-1 gag; this was confirmed by
the following experiment: the single mutant P90A is un-
able to replicate due to its inability to bind CyPA, but
the double mutant P90A A92E is replication competent,
despite its inability to package CyPA into virions.
The second approach that demonstrated that CyPA
is required for a gag-encoded function involved the con-
struction of a chimeric virus in which CA coding se-
quences of the SIVMAC239 DNA provirus were replaced
with those from HIV-1 (Dorfman and Go¨ttlinger, 1996).
Unlike HIV-1, SIVMAC239 does not incorporate CyPA into
virions and replication of the latter is not inhibited by
cyclosporine A (Franke et al., 1994; Thali et al., 1994).
Chimeric virions were capable of incorporating CyPA
and their replication was inhibited by cyclosporine A.
Cyclophilin’s Biochemical Role Gleaned
from Structural Studies
The first high-resolution structural information for a ret-
roviral CA has recently been published (Gamble et al.,
1996; Gitti et al., 1996; Momany et al., 1996). Isolation
of a soluble core domain by limited proteolysis of HIV-1
CA provided the technical breakthrough that led to the
production of a protein preparation sufficiently well-
behaved for structural analysis. The structure of the
amino-terminal two-thirds of CA was solved by NMR
Figure 2. Structure of the HIV-1 CA Core Domain
(Gitti et al., 1996); the X-ray structure of a complex be-
(A) Ribbon representation of the first 151 amino acids of HIV-1 CA
tween this same CA domain and CyPA has been deter- as determined by NMR spectroscopy. Helices I-VII are colored, the
mined (Gamble et al., 1996), and information missing N-terminal b-hairpin is shown in brown, and disordered segments
from a crystal structure of a CA–Fab antibody complex and loops are shown in grey. The position of the P90 side chain in
the exposed loop between helices IV and V is shown.has been provided (Momany et al., 1996).
(B) Detailed view of the exposed proline-rich loop. The position ofIt had been widely suspected that retroviral CA would
the P90 side chain is shown, as is the type II turn formed by residuesbe an eight-stranded, antiparallel b-barrel, the structure
P93 and G94. Hydrogen bonds between A92 and Q95, and between
common to the capsids of many viruses. CyPA is an R97 and W117 on helix VI, are indicated. Figure kindly provided by
eight-stranded, antiparallel b-barrel, and it was appeal- Rossitza K. Gitti, Brian M. Lee, and Michael F. Summers.
ing to imagine the b-sheets of CA and CyPA packed in
a regular array in virions. The actual results were not at
as a complex with CyPA (Gamble et al., 1996). The latterall like the predictions: HIV-1 CA is a triangular pyramid
result is at odds with previous structural studies thatcomposed almost entirely of a-helices (Figure 2A).
had shown that model peptides will only fit within theOne of the few nonhelical elements in CA is an ex-
CyPA hydrophobic pocket in the cis conformation. Gam-posed loop between helices IV and V that is thought to
ble et al. (1996) suggest that the absence of a side chainbe located on the surface of the virion core (Figure 2A).
at the residue preceding P90 allows CA to fit snuglyThe exposed loop corresponds to the proline-rich do-
within the pocket without distortion of the peptide back-main required for CyPA-binding (Franke, Yuan et al.,
bone. Thus, CyPA must promote HIV-1 virion infectivity1994), and is the only part of CA contacting CyPA in the
by forming a stable complex with CA, and not by catalyz-cocrystal (Gamble et al., 1996). The critical G89 and P90
ing the peptidyl-prolyl isomerization of G89-P90.residues are prominently situated at the apex of the loop
CyPA: HIV-1 Core Destabilizer?and are embedded deep in the hydrophobic pocket of
Cytoplasmic fractionation studies indicate that soonCyPA.
after entry HIV-1 CA dissociates from the viral nucleo-Though it is tempting to propose that CyPA catalyzes
protein complex (Gallay et al., 1995). Biochemical analy-cis-trans isomerization of the bond connecting G89 and
ses such as this are difficult to interpret since the per-P90, this appears not to be the case: the bond is primarily
trans in the free protein (Gitti et al., 1996) and all trans centage of infectious particles within any population of
Minireview
1159
retroviral virions is extremely small, and the biologically possess several well-characterized motifs. Nup358/
RanBP2, the largest nuclear pore component, consti-relevant fraction might not be detectable by biochemical
methods; currently there are no methods for confirming tutes the most dramatic example; in addition to a
cyclophilin-homologous domain, this protein possessesthat a given preparation of nucleoprotein complexes is
capable of successfully completing an infection in vivo. a leucine-rich region, Ran-binding sites, nucleoporin-
characteristic repeats, and zinc-fingers (Wu et al., 1995;Assuming that separation of CA from the viral nucleopro-
tein complex is required for productive infection, and Yokohama et al., 1995). The identification of proteins
such as this supports the contention that CyP functionsgiven that CyPA is required for the initiation of reverse
transcription (Braaten et al., 1996b), it would be reason- as a modular protein–protein interaction cassette remi-
niscent of other protein subunits such as the Src homol-able to propose a model in which CyPA promotes HIV-1
CA uncoating (Figure 1) in a manner vaguely analogous ogy domains.
to that of the chaperone Hsp70 in the uncoating of
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CyPs: Specialized Protein Recognition Modules Yokohama, N., Hayashi, N., Seki, T., Pante, N., Ohba, T., Nishii, K.,
Kuma, K., Hayashida, T., Miyata, T., Aebi, U., Fukui, M., and Nishi-Perhaps the greatest significance of these studies with
moto, T. (1995). Nature 376, 184–188.HIV-1 CA is the contribution they make to our under-
standing of the role of CyPs. A growing collection of
data indicates that a primary role of CyPs is to mediate
protein–protein interactions. As a high-affinity complex
with cyclosporine A, CyP creates a composite surface
that inhibits calcineurin (Schreiber and Crabtree, 1992).
The Drosophila CyP NinaA forms a stable complex with
the major isoform of rhodopsin that is required for this
photoreceptor protein to exit the endoplasmic reticulum
(Baker et al., 1994). Now it has been demonstrated that
HIV-1 replication requires the formation of a stable com-
plex between CA and CyPA (Braaten et al., 1996b;
Franke et al., 1994; Thali et al., 1994).
The first CyPs to be cloned were simple molecules
consisting of a core CyP domain and, at most, terminal
extensions that direct subcellular localization. Recently,
CyP family members have been identified which are
components of large macromolecular complexes and
